Cure8

Why This Matters

This study shows a mechanism by which IL-10 protects gut epithelial mitochondria and barrier function during exposure to an IBD-associated E. coli strain, which could be relevant to understanding pathways that maintain remission or limit flares in IBD.

Who Should Pay Attention

Researchers (IBD, mitochondrial biology), translational clinicians, and scientists developing epithelial-protective strategies for IBD.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthFull source text

What To Know

This lab-based study reports that the anti-inflammatory cytokine IL-10 preserves mitochondrial function and epithelial barrier integrity in human colon epithelial cells and organoids challenged with the IBD-associated bacterium adherent-invasive E. coli (AIEC, strain LF82).

The authors link protection to ERK-dependent phosphorylation of STAT3 at serine 727, which supports mitochondrial respiration, membrane potential, and limits permeability transition pore opening and fragmentation.

The work uses in vitro cell lines, human colonic organoids, genetic manipulations of STAT3, and pharmacologic inhibitors to map the signaling pathway; it contrasts IL-10’s effects with IL-22 and highlights a mitochondrial role for STAT3S727.

Keep In Mind

Findings come from in vitro human cell lines and colonic organoids with molecular and pharmacologic experiments; they are mechanistic and not clinical results.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationGut microbes
AuthorsSaranya Navaneetha Krishnan, Amit Jaiswal, Armaan Mohan +3 more
InstitutionGastrointestinal Research Group, Inflammation Research Network, Host-Parasite Interactions Program, Department of Physiology & Pharmacology, Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedApr 23, 2026, 12:00 AM
Content availableFull source text

Conflict statement: The authors have declared that no conflict of interest exists.

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →